Today's News
ELAL 800×100
Peerles 800×100
S&P 600×100
Community Sports 800×100
Shlomo Artzi 800×100
Israel Bond RRSP Jan 2017
S&P 600×100
ELAL 600×100
Varicose veins. Photo: CIJnews

Health Canada approved microfoam for treatment of varicose veins

BTG International Canada Inc., part of global specialist healthcare company BTG (LSE: BTG), announced on January 26, 2017 the Canadian commercial launch of Varithena™ (polidocanol injectable foam), a drug/device combination product used to treat varicose veins.

Varithena™ is intended for use in adults with clinically significant venous reflux as diagnosed by duplex ultrasound.

Varithena™ is a uniform, low nitrogen, polidocanol microfoam dispensed from a proprietary canister device.

A physician injects a small amount of Varithena™ into the malfunctioning vein of a patient through a small tube (catheter) or a needle. It displaces the blood from the vein to reach and treat the vein wall; the diseased vein collapses and blood flow is diverted to healthy veins nearby. For further information click HERE.

ELAL 600×100
Buzaker 600×100
S&P 600×100
Israel Bond RRSP Jan 2017

About CIJnews Staff

CIJnews Staff
CIJnews is an independent, dynamic and reliable online news source that serves the Canadian Jewish and Israeli communities and provides an uncensored platform for the spectrum of voices.

Send this to friend